Metraipolis › archive › dc_a62da43840a4
Dual-Target Inhibition of CDK5 and PBK in Pituitary Neuroendocrine Tumors: Mechanisms and Therapeutic Potential — Europe PMC PMID:42650106
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42650106
- DOI
- 10.3390/genes17080909
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T06:31:18.609Z
- SHA-256 of the archived text
92afe95c6e8e2dea008158ce474883ad0223052458055ca46f871e7b33b39ed0- Stable URL of this page
https://metraipolis.com/documento/dc_a62da43840a4
How to cite
Dual-Target Inhibition of CDK5 and PBK in Pituitary Neuroendocrine Tumors: Mechanisms and Therapeutic Potential — Europe PMC PMID:42650106 — Europe PMC (en), https://europepmc.org/article/MED/42650106 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a62da43840a4 (Metraipolis archive dc_a62da43840a4, sha256 92afe95c6e8e2dea008158ce474883ad0223052458055ca46f871e7b33b39ed0)
BibTeX
@misc{dca62da43840a4,
title = {Dual-Target Inhibition of CDK5 and PBK in Pituitary Neuroendocrine Tumors: Mechanisms and Therapeutic Potential — Europe PMC PMID:42650106},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42650106},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a62da43840a4; sha256 92afe95c6e8e2dea008158ce474883ad0223052458055ca46f871e7b33b39ed0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42650106. Agents can read the archived copy with the MCP tool read_document.